Frontotemporal Dementia Testing: How It Is Diagnosed

Frontotemporal dementia is usually diagnosed through a careful clinical workup, not by one stand-alone test. The process often starts because family members notice changes in personality, judgment, empathy, language, eating habits, or behavior that do not fit the person’s usual character.

Testing matters because frontotemporal dementia can look like depression, bipolar disorder, Alzheimer’s disease, a sleep disorder, medication effects, stroke, or another neurological condition. A good evaluation looks for the pattern of symptoms, checks how the brain is functioning, rules out treatable causes, and decides whether the findings fit a specific type of frontotemporal dementia.

Table of Contents

• What FTD Testing Can and Cannot Prove
• Symptoms That Lead to FTD Testing
• The First Appointment and History
• Cognitive, Language, and Behavioral Tests
• Brain Scans, Labs, and Sleep Testing
• Genetic Testing and Biomarkers
• Conditions Doctors Need to Rule Out
• After Diagnosis: Results and Next Steps

What FTD Testing Can and Cannot Prove

Frontotemporal dementia testing is a structured workup that combines history, examination, cognitive testing, brain imaging, and selected lab or genetic tests. In most people, the diagnosis is clinical: doctors look for a progressive pattern that fits FTD and does not fit a more likely explanation.

FTD is not one single disease pattern. It is a group of disorders involving the frontal and temporal areas of the brain, which help control behavior, judgment, social awareness, language, and emotional response. The main clinical forms include:

• Behavioral variant frontotemporal dementia, often marked by personality change, loss of inhibition, apathy, compulsive behavior, loss of empathy, poor judgment, or changes in eating.
• Primary progressive aphasia, where language decline is the main early feature. This may involve difficulty speaking, grammar problems, word-finding trouble, or loss of word meaning.
• FTD with movement symptoms, which may overlap with amyotrophic lateral sclerosis, corticobasal syndrome, progressive supranuclear palsy, or parkinsonism-like symptoms.

A common source of confusion is the difference between a clinical diagnosis and a confirmed disease process. A clinician may diagnose probable FTD based on symptoms, progression, functional decline, and imaging findings. A definite diagnosis of the underlying brain pathology may require a known disease-causing genetic variant or examination of brain tissue after death. That does not mean testing is “guesswork.” It means that modern diagnosis relies on converging evidence rather than a single yes-or-no scan.

The first goal is to decide whether the person has a progressive neurodegenerative syndrome. The second is to identify the most likely type. The third is to rule out conditions that can mimic FTD and may need different treatment. This is why an FTD workup may include tests that do not “test for FTD” directly, such as blood work, sleep testing, medication review, depression assessment, or Alzheimer’s biomarkers.

FTD can be harder to recognize than memory-led dementias because early memory may be relatively preserved. A person may remember appointments or recent events but begin making unsafe financial decisions, saying socially inappropriate things, losing interest in family, overeating sweets, repeating routines, or struggling to produce words. Families may describe the person as “not themselves,” while the person may not recognize that anything has changed.

For comparison, an Alzheimer’s diagnostic workup often gives more weight to memory decline and Alzheimer’s-specific biomarkers. In FTD, behavior, language, executive function, social cognition, and frontal-temporal brain changes are usually more central.

Symptoms That Lead to FTD Testing

FTD testing is usually considered when changes in behavior, personality, language, judgment, or social awareness are progressive and hard to explain by stress alone. The pattern matters more than one isolated symptom.

In behavioral variant FTD, family members often notice changes before the person does. The person may become unusually blunt, impulsive, emotionally distant, apathetic, rigid, or socially inappropriate. They may lose empathy, neglect hygiene, repeat phrases or actions, develop new food cravings, eat excessively, make risky purchases, or show poor awareness of consequences. These symptoms can be especially alarming because they may look intentional, selfish, or psychiatric when they are actually related to brain network changes.

Language-led FTD can look very different. A person may have increasing trouble finding words, naming objects, understanding word meanings, speaking fluently, forming grammatically correct sentences, or following complex conversation. Unlike a stroke, the change is gradual. Unlike ordinary word-finding lapses, it worsens over time and begins to interfere with work, relationships, or daily tasks.

Some people also develop movement or motor symptoms. These can include muscle weakness, twitching, stiffness, falls, tremor-like symptoms, trouble swallowing, changes in walking, or difficulty coordinating hand movements. When these symptoms appear with behavior or language changes, a neurologist may look for overlap between FTD and motor neuron disease or atypical parkinsonian syndromes.

Warning patterns that should prompt medical evaluation include:

• A clear personality change that persists and worsens.
• New disinhibition, poor judgment, scams, unsafe driving, or financial risk-taking.
• Loss of empathy or emotional warmth that is very out of character.
• Apathy that looks like depression but does not include sadness or guilt.
• Repetitive, compulsive, or ritualized behaviors.
• New overeating, sweet cravings, alcohol misuse, or eating nonfood items.
• Gradual decline in speech, grammar, naming, or word comprehension.
• Declining work performance, household management, or social functioning.
• Family history of FTD, ALS, or early-onset dementia.

Some symptoms need urgent evaluation rather than a routine dementia workup. Sudden confusion, sudden weakness, facial droop, severe headache, seizure, fever with confusion, new hallucinations with agitation, suicidal thoughts, threats of violence, or rapid decline over days to weeks can point to stroke, delirium, infection, medication toxicity, seizure disorder, or another urgent condition. In those situations, guidance on emergency care for neurological or mental health symptoms may be more relevant than waiting for an outpatient dementia appointment.

The First Appointment and History

The first appointment is often the most important part of FTD testing because the diagnosis depends heavily on the timeline and real-world behavior changes. A family member, partner, or close friend should be involved whenever possible because people with FTD may have limited insight into their symptoms.

The clinician will usually ask when changes began, what changed first, how quickly symptoms progressed, and how the changes affect daily life. Specific examples are more useful than general descriptions. “He is different” is understandable, but “he spent thousands of dollars impulsively,” “she no longer recognizes sarcasm,” or “he repeats the same meal routine every day” gives the clinician clearer diagnostic information.

A detailed history may cover:

• Work performance and errors.
• Driving safety and traffic violations.
• Financial judgment, scams, or unusual spending.
• Social behavior, tact, empathy, and emotional response.
• Eating habits, alcohol use, and impulse control.
• Language changes in speech, writing, reading, and comprehension.
• Hygiene, household routines, and self-care.
• Sleep quality, snoring, dream enactment, or daytime sleepiness.
• Depression, mania, psychosis, anxiety, trauma, or substance use symptoms.
• Medication changes, including sedatives, anticholinergic drugs, opioids, steroids, or dopamine-related medicines.
• Family history of dementia, ALS, Parkinson’s disease, psychiatric illness, or early neurological decline.

The physical and neurological exam looks for clues that may support or challenge an FTD diagnosis. The doctor may check eye movements, reflexes, muscle tone, gait, coordination, speech, swallowing, strength, and signs of motor neuron disease. These findings can help distinguish FTD from stroke, Parkinson’s-related disorders, normal pressure hydrocephalus, brain tumors, inflammatory disease, or medication effects.

Primary care clinicians may begin the workup, but suspected FTD often benefits from referral to a neurologist, behavioral neurologist, geriatric psychiatrist, neuropsychologist, or memory disorders clinic. If the main symptoms are language-based, speech-language pathology may also be involved. If symptoms are mainly behavioral or psychiatric, a psychiatrist may help evaluate mood, psychosis, bipolar disorder, compulsive symptoms, and safety risk.

Families can prepare by writing a brief timeline before the visit. Include the first symptom, major changes by year or month, examples of risky behavior, changes in work or finances, medications, alcohol or drug use, sleep symptoms, and family history. This kind of timeline can prevent important details from being missed during a stressful appointment.

Cognitive, Language, and Behavioral Tests

Cognitive and neuropsychological testing helps show which brain functions are weak, which are relatively preserved, and whether the pattern fits FTD. These tests do not diagnose FTD alone, but they can strongly support or weaken the diagnosis.

Brief office screens may include tests of memory, attention, orientation, clock drawing, naming, verbal fluency, and executive function. Common cognitive screens can detect cognitive impairment, but they may miss early FTD if the test relies heavily on memory and orientation. A person with early behavioral variant FTD may do reasonably well on a short memory screen while still having serious problems with judgment, impulse control, empathy, or social reasoning.

A full neuropsychological evaluation is more detailed. It may assess:

• Executive function: planning, inhibition, mental flexibility, problem-solving, and error monitoring.
• Language: naming, repetition, grammar, fluency, comprehension, reading, and writing.
• Memory: learning, recall, recognition, and whether memory improves with cues.
• Attention and processing speed: concentration, speed, and mental tracking.
• Social cognition: emotion recognition, understanding others’ perspectives, sarcasm, and social judgment.
• Visuospatial skills: drawing, object location, and spatial reasoning.
• Mood and behavior: depression, anxiety, apathy, impulsivity, compulsions, irritability, and insight.

In many FTD evaluations, social cognition is especially important. A person may perform adequately on standard memory tasks but struggle to read facial emotion, infer another person’s feelings, or recognize that a behavior is socially inappropriate. These skills are closely tied to frontal and temporal brain networks.

Language testing is central when primary progressive aphasia is suspected. The examiner may listen for effortful speech, grammar errors, sound distortions, word-finding pauses, impaired naming, trouble understanding single words, or difficulty repeating phrases. The pattern can help separate nonfluent/agrammatic, semantic, and logopenic forms of progressive aphasia. This distinction matters because not all progressive aphasia is caused by the same underlying disease process.

A neuropsychologist also considers effort, mood, education, language background, hearing, vision, and cultural factors. Testing should not be interpreted as a simple pass-fail score. The pattern across tests, the person’s baseline abilities, and the real-life history are what make the results meaningful.

For families, neuropsychological testing for dementia and memory loss can be useful when the diagnosis is unclear, when work capacity or driving safety is in question, or when doctors need a baseline to compare with future changes. It can also help distinguish FTD from depression, Alzheimer’s disease, ADHD, substance effects, or sleep-related cognitive symptoms.

Brain Scans, Labs, and Sleep Testing

Brain scans and medical tests are used to support the diagnosis, look for FTD-like patterns, and rule out treatable or alternative causes. Normal results do not always exclude early FTD, but abnormal findings can be very helpful when they match the clinical picture.

MRI is often the preferred structural brain scan. It can show shrinkage, called atrophy, in the frontal and temporal lobes. The pattern may be asymmetric, meaning one side is affected more than the other. MRI also helps look for strokes, tumors, bleeding, normal pressure hydrocephalus, significant vascular disease, inflammation, or other structural problems.

CT may be used when MRI is not available or cannot be done, but MRI usually gives more detail. FDG-PET can show areas of reduced brain metabolism, often before atrophy is obvious on MRI. In FTD, this may involve frontal or anterior temporal regions. Amyloid PET or Alzheimer’s blood or CSF biomarkers may be considered when the main question is whether the symptoms are more likely due to Alzheimer’s disease than FTD.

A broader review of MRI and PET for memory and cognitive symptoms can help families understand why different scans are chosen for different diagnostic questions.

Blood tests do not diagnose FTD directly, but they are important because many medical problems can affect thinking, behavior, mood, and energy. Depending on the situation, clinicians may check blood count, electrolytes, liver and kidney function, thyroid function, vitamin B12, folate, inflammatory markers, infections, blood sugar, and other tests based on symptoms. A focused discussion of blood tests in cognitive workups can be helpful when families wonder why labs are ordered during a dementia evaluation.

Sleep testing may be recommended when symptoms suggest obstructive sleep apnea, REM sleep behavior disorder, severe insomnia, or another sleep disorder. Sleep apnea can cause poor concentration, irritability, slowed thinking, depression-like symptoms, and memory complaints. It does not usually explain the full behavioral and language pattern of FTD, but untreated sleep problems can worsen functioning and confuse the picture.

Test or assessment	Why it is used	What it cannot do alone
Clinical history	Identifies the timeline, progression, and real-world behavior or language changes	Cannot confirm the underlying brain pathology by itself
Neurological exam	Looks for movement, reflex, speech, gait, and motor neuron signs	May be normal in early FTD
Neuropsychological testing	Maps executive, language, memory, and social cognition patterns	Cannot diagnose FTD without clinical context
MRI or CT	Looks for atrophy and rules out structural causes such as tumor, stroke, or bleeding	May not show clear changes early
FDG-PET	Shows patterns of reduced brain metabolism that may support FTD	Does not always identify the exact underlying protein disease
Blood tests	Checks for medical mimics or contributors	Does not directly diagnose most FTD cases

Genetic Testing and Biomarkers

Genetic testing is considered when FTD begins young, runs in the family, overlaps with ALS, or has features that suggest an inherited form. It should usually be paired with genetic counseling because results can affect relatives as well as the person being tested.

The most common genes associated with familial FTD include C9orf72, GRN, and MAPT, though other genes can be involved. A positive result can confirm a genetic form of FTD in a person with compatible symptoms. It may also help relatives understand their own risk, guide family planning, and determine eligibility for research or future targeted therapies.

A negative genetic test does not rule out FTD. Many people with FTD do not have an identifiable disease-causing variant on current clinical testing. In other cases, a test may find a variant of uncertain significance, which means the result is not clearly disease-causing and should not be treated as a definite answer.

Predictive testing for an adult who has no symptoms but has a known familial mutation is a separate decision. It can have emotional, financial, insurance, employment, and family implications. People considering this type of testing should have pre-test counseling, time to decide, and support for either result. Testing children for adult-onset FTD risk is generally avoided unless there is a clear medical reason during childhood.

Families who are considering this step may benefit from learning what happens during genetic counseling before dementia testing, especially if several relatives have had early dementia, ALS, or unexplained behavioral changes.

Biomarkers are another evolving area. Some tests measure proteins or biological changes in blood or cerebrospinal fluid. Neurofilament light chain, often called NfL, may be elevated when there is active neurodegeneration, but it is not specific to FTD. Alzheimer’s biomarkers, including amyloid and tau tests, may help when doctors are trying to distinguish Alzheimer’s disease from FTD. These tests can be useful in the right context, but they are not a substitute for history, examination, cognitive testing, and imaging.

This area is changing quickly, especially in research and specialty clinics. Some biomarker tests are used mainly to support differential diagnosis or clinical trial enrollment rather than to give a stand-alone diagnosis. A careful clinician will explain what a test can show, what it cannot show, and how the result would change management before ordering it.

Conditions Doctors Need to Rule Out

A major part of FTD diagnosis is ruling out other conditions that can cause similar symptoms. This step is not a delay or a formality; it is essential because several look-alike conditions are treatable or require very different care.

Psychiatric conditions are among the most common sources of confusion. Depression can cause apathy, withdrawal, slowed thinking, and poor self-care. Bipolar disorder can cause impulsivity, poor judgment, spending, irritability, or disinhibition. Psychotic disorders can cause unusual beliefs or behavior. Obsessive-compulsive symptoms can resemble repetitive behaviors. Substance use can also change personality, impulse control, sleep, and cognition.

The difference is not always obvious. FTD is more likely when symptoms begin later than a person’s usual psychiatric history, steadily worsen, include loss of empathy or social awareness, show limited insight, and are paired with frontal or temporal changes on imaging or a characteristic neuropsychological pattern. Psychiatric illness remains possible, especially when symptoms fluctuate, respond strongly to treatment, or fit a long-standing mood or anxiety pattern.

Dementia-related conditions also need careful comparison. Alzheimer’s disease more often begins with prominent episodic memory problems, though some forms can affect language or behavior. Lewy body dementia may involve visual hallucinations, fluctuations in alertness, REM sleep behavior disorder, parkinsonism, and sensitivity to antipsychotic medicines. Vascular cognitive impairment may follow strokes or appear with significant vascular disease on imaging. Normal pressure hydrocephalus can cause walking trouble, urinary symptoms, and cognitive changes.

Families trying to understand overlapping symptoms may find it useful to compare depression and dementia or the workup for Lewy body dementia testing, since both can enter the differential diagnosis.

Medical and neurological mimics may include thyroid disease, vitamin B12 deficiency, sleep apnea, seizures, autoimmune or inflammatory brain disease, infections, medication side effects, alcohol-related cognitive disorder, traumatic brain injury, brain tumors, and delirium. Rapid decline, prominent hallucinations, fever, seizures, severe headache, sudden neurological symptoms, or major day-to-day fluctuation should make clinicians look especially hard for alternatives.

The best evaluations avoid two mistakes. The first is dismissing FTD-like symptoms as “just stress” or “just depression” without checking the pattern. The second is diagnosing FTD too quickly when a treatable condition, medication effect, or primary psychiatric disorder has not been properly evaluated.

After Diagnosis: Results and Next Steps

After testing, the clinician should explain the level of certainty, the most likely diagnosis, what alternatives were considered, and what should happen next. Families should leave with more than a label; they need a plan for safety, follow-up, support, and future decisions.

Results may be described as possible FTD, probable FTD, a specific FTD syndrome, another dementia, mild cognitive impairment, psychiatric illness, or an unclear diagnosis that needs monitoring. Uncertainty is common early on. Sometimes doctors repeat cognitive testing or imaging after 6 to 12 months to see whether the pattern progresses. Progression over time can clarify the diagnosis.

A useful results discussion should cover:

1. Which symptoms support the diagnosis. Ask what parts of the history, testing, or imaging point toward FTD.
2. Which findings argue against it. This helps explain uncertainty and prevents overconfidence.
3. Whether more testing is needed. This may include MRI, FDG-PET, lumbar puncture, Alzheimer’s biomarkers, genetic testing, sleep testing, or psychiatric evaluation.
4. What safety issues need action now. Driving, finances, cooking, medication management, weapons access, scams, wandering, and workplace risk may need attention.
5. Who will coordinate care. FTD often requires neurology, primary care, psychiatry, speech-language therapy, social work, occupational therapy, and caregiver support.
6. How the diagnosis will be followed. Follow-up helps track progression, adjust care, and revisit uncertain findings.

There is currently no cure for FTD, but diagnosis still matters. It can prevent inappropriate treatment, reduce blame, guide speech and behavioral strategies, support disability planning, and help families make legal and financial decisions while the person can still participate. It may also open the door to clinical trials, genetic counseling, and support organizations focused on FTD.

Practical next steps often include creating a medication list, simplifying routines, limiting financial access if judgment is impaired, reviewing driving safety, setting up durable power of attorney, discussing advance care planning, and documenting behavior triggers. Speech therapy may help people with language-led FTD develop communication supports. Caregiver training can be as important as medication because many symptoms are managed through environment, structure, and response strategies.

Families should also ask what changes would require urgent contact. Rapid worsening, falls, choking, severe agitation, hallucinations, suicidal statements, threats, unsafe wandering, inability to manage basic needs, or sudden neurological symptoms should not wait for a routine follow-up.

A diagnosis of FTD can be emotionally difficult because it often affects identity, relationships, work, and family roles earlier than expected. Clear testing cannot remove that burden, but it can replace confusion with a more accurate explanation and a practical path forward.

References

• Frontotemporal dementia – Diagnosis and treatment 2026 (Clinical Guidance)
• Clinical recognition of frontotemporal dementia with right temporal predominance: a consensus statement from the International Working Group 2025 (Consensus Statement)
• Nuts and Bolts of Consensus Recommendations of Biomarkers and Genetic Testing to Differentiate Behavioral Variant Frontotemporal Dementia From Primary Psychiatric Disorders 2024 (Consensus Summary)
• Frontotemporal lobar degeneration 2023 (Review)
• Frontotemporal Dementia, Where Do We Stand? A Narrative Review 2023 (Review)

Disclaimer

This information is for general educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Changes in behavior, language, judgment, memory, movement, or safety should be discussed with a qualified healthcare professional, and sudden or dangerous symptoms should be evaluated urgently.

If this article helped clarify how frontotemporal dementia is diagnosed, consider sharing it on Facebook, X (formerly Twitter), or your preferred platform.